Fullmektig i Norge:
Org.nummer: 979993269
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2009.06.02, EP 09305506
"Chemidex Pharma Ltd, Lyflex 5 mg/5ml oral solution" INTERNET CITATION, [Online] XP002476376 Retrieved from the Internet: URL:http://emc.medicines.org.uk/emc/assets /c/html/displaydoc.asp?document id=14939> [retrieved on 2008-04-14] (B1)
ZU HOERSTE GERD MEYER ET AL: "Myelin disorders: Causes and perspectives of Charcot-Marie-Tooth neuropathy" JOURNAL OF MOLECULAR NEUROSCIENCE, BIRKHAEUSER, CAMBRIDGE, MA, US, vol. 28, no. 1, 1 January 2006 (2006-01-01), pages 77-88, XP008090275 ISSN: 0895-8696 (B1)
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US 1977 BERENBAUM M C: 'SYNERGY ADDITIVISM AND ANTAGONISM IN IMMUNO SUPPRESSION A CRITICAL REVIEW' Database accession no. PREV197866036009 & BERENBAUM M C: "SYNERGY ADDITIVISM AND ANTAGONISM IN IMMUNO SUPPRESSION A CRITICAL REVIEW", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, vol. 28, no. 1, 1977, pages 1-18, ISSN: 0009-9104 (B1)
EP-A- 0 778 023 (B1)
GALLAGHER P ET AL: "Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia" JOURNAL OF PSYCHIATRIC RESEARCH, ELSEVIER LTD, GB, vol. 42, no. 12, 1 October 2008 (2008-10-01), pages 1037-1041, XP023905451 ISSN: 0022-3956 [retrieved on 2008-02-05] (B1)
GIRONI M ET AL: "A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis" MULTIPLE SCLEROSIS, SAGE PUBLICATIONS, BASINGSTOKE, GB, vol. 14, no. 8, 1 September 2008 (2008-09-01), pages 1076-1083, XP009124628 ISSN: 1352-4585 (B1)
HERRMANN D N: "Experimental Therapeutics in Hereditary Neuropathies: The Past, the Present, and the Future" NEUROTHERAPEUTICS,, vol. 5, no. 4, 1 January 2008 (2008-01-01) , pages 507-515, XP009124626 ISSN: 1933-7213 (B1)
KELTNER J L ET AL: "Myotonic pupils in Charcot-Marie-Tooth disease. Successful relief of symptoms with 0.025% pilocarpine" ARCHIVES OF OPHTHALMOLOGY, AMERICAN MEDICAL ASSOCIATION, US, vol. 93, no. 11, 1 January 1975 (1975-01-01), pages 1141-1148, XP008090277 ISSN: 0003-9950 (B1)
LEES A J ET AL: "BACLOFEN IN PARKINSON'S DISEASE" JOURNAL OF NEUROLOGY NEUROSURGERY & PSYCHIATRY, BMJ PUBLISHING GROUP, GB, vol. 41, 1 January 1978 (1978-01-01), page 707/708, XP000981829 ISSN: 0022-3050 (B1)
NORRIS F H ET AL: "TRIAL OF BACLOFEN IN AMYOTROPHIC LATERAL SCLEROSIS" ARCHIVES OF NEUROLOGY, AMERICAN MEDICAL ASSOCIATION, CHICAGO, IL, US, vol. 36, 1 November 1979 (1979-11-01), page 715/716, XP000981818 ISSN: 0003-9942 (B1)
POMARA N ET AL: "MIFEPRISTONE (RU 486) FOR ALZHEIMER'S DISEASE" NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA, US, vol. 58, no. 9, 1 May 2002 (2002-05-01), XP008031502 ISSN: 0028-3878 (B1)
SLAVIK J ET AL: "Sa.25. In Vitro Correlates of in Vivo Rapamycin Therapy in Patients with Multiple Sclerosis" CLINICAL IMMUNOLOGY, ACADEMIC PRESS, US, vol. 119, 1 January 2006 (2006-01-01), page S113, XP024911484 ISSN: 1521-6616 [retrieved on 2006-01-01] (B1)
WILCOCK G K ET AL: "A placebo-controlled, double-blind trial of the selective AB-42 lowering agent, flurizan (MPC-7869, (R)-flurbiprofen) in patients with mild to moderate Alzheimer's disease" ALZHEIMER'S & DEMENTIA: THE JOURNAL OF THE ALZHEIMER'SASSOCIATION, ELSEVIER, NEW YORK, NY, US, vol. 1, no. 1, 1 July 2005 (2005-07-01), page S95, XP025350528 ISSN: 1552-5260 [retrieved on 2005-08-12] (B1)
WO-A-2004/006911 (B1)
WO-A-2006/117573 (B1)
WO-A1-2009/153291 (B1)
CINTAS P: "Drug therapy for symptomatic relief in ALS-Quels sont les traitments medicamenteux symptomatiques?" REVUE NEUROLOGIQUE, MASSON, PARIS, FR, vol. 162, no. Sp. Issue 2, 1 June 2006 (2006-06-01), pages 4S235-4S243, XP009124633 ISSN: 0035-3787 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Utgående
EP Påminnelse om ikke betalt årsavgift (3331) (PTEP2437742)
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Batch Varsel om betaling av første årsavgift (3319)
|
Utgående
EP Registreringsbrev
|
Innkommende, AR81070646
Korrespondanse (Hovedbrev inn)
|
Utgående
EP defect letter
|
Innkommende, AR80342363
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Forsinkelsesavgift patent | 2024.11.29 | 700 | Davide Chiesa | Betalt og godkjent |
Årsavgift 15. avg. år (EP) | 2024.11.29 | 6310 | Davide Chiesa | Betalt og godkjent |
Årsavgift 14. avg. år (EP) | 2023.05.19 | 4500 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 13. avg. år (EP) | 2022.05.18 | 4200 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 12. avg. år (EP) | 2021.05.20 | 3850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 11. avg. år (EP) | 2020.05.22 | 3500 | 1/IPAN GMBH | Betalt og godkjent |
Årsavgift 10. avg. år (EP) | 2019.05.23 | 3200 | 1/IPAN GMBH | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2018.05.22 | 2850 | 1/IPAN GMBH | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2017.05.23 | 2550 | 1/IPAN GMBH | Betalt og godkjent |
Årsavgift 7. avg. år (EP) | 2016.05.26 | 2200 | IPAN GMBH | Betalt og godkjent |
Årsavgift 6. avg. år (EP) | 2015.05.28 | 2000 | IPAN GMBH | Betalt og godkjent |
31415318 expand_more expand_less | 2014.12.08 | 12700 | Bryn Aarflot AS | Betalt |
Valideringsavgift EP-patent tillegg >14 sider
11500 = 46 X 250
Valideringsavgift EP-patent
1200 = 1 X 1200
|